Gengos Andrew sold TERN
May 5, 2026 · Form 4 insider transaction
Gengos Andrew sold 68,750 shares of Terns Pharmaceuticals Inc at $53.00 per share, a transaction worth $3.64M. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
68,750
Price
$53.00
Total value
$3.64M
InsiderGengos Andrew
RoleOfficer
SecurityCommon Stock
Transaction codeD: Disposition to the issuer
Transaction dateMay 5, 2026
Filing dateMay 5, 2026
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Pursuant to the Merger Agreement, each Issuer restricted stock unit ("RSU") award then outstanding, whether or not vested, was cancelled and converted into the right to receive an amount in cash, without interest thereon and subject to applicable withholding taxes, equal to the product of the Merger Consideration and the total number of Shares subject to such RSU award as of immediately prior to the Effective Time (as defined in the Merger Agreement).